Replies to post #347820 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

The data was simply supposed to provide some perspective on the range of royalties paid to developers of drugs that were subsequently APPROVED.

Pointing out that there is precedent for a company in phase 2 getting more than a 25% royalty is as valuable as pointing out that the same table shows that 26 companies in phase 2 signed deals where the royalties were from 0-5%.
Obviously many factors play into how the math is done by both the licensor and the licensee.

When someone suggested regarding a B-OM license that "We'd only get 6% of that from our license" you responded "You forgot to mention that the 6% royalty figure is purely an assumption on your part. It could be much higher."

And here we go again. I regret posting the table....

[Lemoncat]

Yep there's a precedent. The numbers tell us one of two things.

1. There's a 1/72 chance of us getting 25%+.

2. If Brilacidin is more profitable than 71/72 of those drugs we have a good chance of a 25% royalty.

Go IPIX!